Asset profile
Phenobarbital sodium injection (Sezaby)
Small molecule
Evidence outlook
Approved: Epilepsy
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
72 competitors in this universe: 9 direct rivals (same mechanism and indication), 3 same-class, 60 same-indication.
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Phenobarbital Sodium Injection (Sezaby): this drug | Approved | Small molecule | GABA-A receptor | ||
| Clobazam (Onfi) | Approved | Small molecule | GABA-A receptor | ||
| Diastat | Approved | Combination | GABA-A receptor | ||
| Diazepam (Valium) | Approved | Small molecule | GABA-A receptor | ||
| Diazepam (Valtoco) | Approved | Small molecule | GABA-A receptor | ||
| Ganaxolone | Approved | Small molecule | GABA-A receptor | ||
| Midazolam (Nayzilam) | Approved | Small molecule | GABA-A receptor, GABA-A receptor (benzodiazepine site) | ||
| Stiripentol | Approved | Small molecule | GABA-A receptor | ||
| Diazepam (Libervant) | Phase 3 | Small molecule | GABA-A receptor | ||
| Staccato Alprazolam | Phase 3 | Combination | GABA-A receptor | ||
| KH607 | Phase 3 | Small molecule | GABA-A receptor | ||
| GlyphAllo (allopregnanolone Prodrug) (SPT-300) | Phase 2 | Small molecule | GABA-A receptor | ||
| HS-10353 | Phase 2 | Small molecule | GABA-A receptor | ||
| Brivaracetam | Approved | Small molecule | Synaptic vesicle glycoprotein 2A (SV2A) | ||
| Cannabidiol (Epidiolex) | Approved | Small molecule | GPR55 / TRPV1 / adenosine transport (multi-target), cannabinoid | ||
| Carbamazepine | Approved | Small molecule | Sodium channels |
…and 57 more. Research shows the complete landscape.
Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Compare head-to-head
3 further head-to-head pairs are tracked; the rosters on each shared mechanism and indication page list every rival in the race.
Upcoming events
No upcoming readouts on record for this asset.
All registered studies
Unlock the complete ClinicalTrials.gov registry
Research includes every linked study, indication filters, phase grouping and featured-trial cross-links.